OPKO Health, Inc. (OPK)
Largest Insider Buys in Sector
OPK Stock Price History Chart
OPK Stock Performance
About OPKO Health, Inc.
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers …
Insider Activity of OPKO Health, Inc.
Over the last 12 months, insiders at OPKO Health, Inc. have bought $11.36M and sold $0 worth of OPKO Health, Inc. stock.
On average, over the past 5 years, insiders at OPKO Health, Inc. have bought $9.51M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: FROST PHILLIP MD ET AL (CEO & Chairman) — $70.8M. Zerhouni Elias A. (Vice Chairman and President) — $1.03M. HSIAO JANE PH D (Vice Chairman & CTO) — $800,116.
The last purchase of 100,000 shares for transaction amount of $126,937 was made by FROST PHILLIP MD ET AL (CEO & Chairman) on 2024‑05‑23.
List of Insider Buy and Sell Transactions, OPKO Health, Inc.
| 2024-05-23 | CEO & Chairman | 100,000 0.0142% | $1.27 | $126,937 | +15.23% | |||
| 2024-05-17 | CEO & Chairman | 163,997 0.0229% | $1.29 | $211,195 | +12.21% | |||
| 2024-03-18 | CEO & Chairman | 500,000 0.0725% | $0.87 | $437,100 | +58.29% | |||
| 2024-03-14 | CEO & Chairman | 500,000 0.0693% | $0.89 | $444,300 | +53.60% | |||
| 2024-03-13 | CEO & Chairman | 500,000 0.0723% | $0.93 | $463,750 | +46.10% | |||
| 2024-03-12 | CEO & Chairman | 600,000 0.0865% | $0.93 | $559,380 | +46.57% | |||
| 2024-02-28 | CEO & Chairman | 500,000 0.0718% | $0.99 | $496,150 | +36.99% | |||
| 2024-02-21 | CEO & Chairman | 1M 0.1283% | $0.99 | $991,700 | +32.67% | |||
| 2024-02-07 | CEO & Chairman | 1.5M 0.1855% | $0.98 | $1.46M | +32.00% | |||
| 2024-01-29 | director | 30,000 0.0038% | $0.99 | $29,838 | +26.57% | |||
| 2024-01-19 | CEO & Chairman | 500,000 0.0634% | $0.98 | $488,650 | +31.79% | |||
| 2024-01-18 | CEO & Chairman | 400,000 0.0506% | $0.97 | $386,200 | +32.97% | |||
| 2024-01-17 | Vice Chairman & CTO | 150,000 0.0187% | $0.95 | $142,500 | +32.60% | |||
| 2024-01-16 | CEO & Chairman | 1M 0.1308% | $0.95 | $954,300 | +37.89% | |||
| 2024-01-11 | CEO & Chairman | 511,531 0.0649% | $0.94 | $480,379 | +35.12% | |||
| 2024-01-08 | Chief Innovation Officer | 216,184 0.026% | $0.93 | $200,427 | +31.71% | |||
| 2024-01-05 | CEO & Chairman | 1.5M 0.1951% | $0.90 | $1.34M | +45.87% | |||
| 2024-01-05 | Vice Chairman & CTO | 150,010 0.019% | $0.87 | $130,899 | +45.87% | |||
| 2024-01-05 | Vice Chairman and President | 550,300 0.0746% | $0.93 | $514,093 | +45.87% | |||
| 2024-01-05 | Executive VP-Administration | 10,000 0.0013% | $0.87 | $8,669 | +45.87% |
Insider Historical Profitability
| FROST PHILLIP MD ET AL | CEO & Chairman | 211232222 30.2896% | $1.45 | 1143 | 0 | +10.39% |
| HSIAO JANE PH D | Vice Chairman & CTO | 27999880 4.015% | $1.45 | 27 | 0 | +7.49% |
| Zerhouni Elias A. | Vice Chairman and President | 20327814 2.9149% | $1.45 | 2 | 0 | <0.0001% |
| Rubin Steven D | Executive VP-Administration | 6187732 0.8873% | $1.45 | 15 | 2 | <0.0001% |
| PAGANELLI JOHN A | director | 384340 0.0551% | $1.45 | 6 | 0 | <0.0001% |
Institutional Investor Ownership
| BlackRock | $39.87M | 4.77 | 33.23M | -10.11% | -$4.48M | <0.01 | |
| The Vanguard Group | $35.4M | 4.23 | 29.5M | -25.79% | -$12.3M | <0.01 | |
| State Street | $12.24M | 1.46 | 10.2M | +9.63% | +$1.08M | <0.01 | |
| Geode Capital Management | $11.97M | 1.43 | 9.97M | +2.6% | +$302,659.93 | <0.01 | |
| Charles Schwab | $6.97M | 0.83 | 5.81M | +1.32% | +$90,717.60 | <0.01 |